Virtus Lifesci Biotech Etf Probability of Future Etf Price Finishing Under 37.44

BBP Etf  USD 56.38  0.92  1.66%   
Virtus LifeSci's implied volatility is one of the determining factors in the pricing options written on Virtus LifeSci Biotech. Implied volatility approximates the future value of Virtus LifeSci based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Virtus LifeSci Biotech over a specific time period. For example, 2024-04-19 CALL at $55.0 is a CALL option contract on Virtus LifeSci's common stock with a strick price of 55.0 expiring on 2024-04-19. The contract was not traded in recent days and, as of today, has 22 days remaining before the expiration. The option is currently trading at a bid price of $0.15, and an ask price of $4.2. The implied volatility as of the 28th of March is 20.51. View All Virtus options

Closest to current price Virtus long CALL Option Payoff at Expiration

Virtus LifeSci's future price is the expected price of Virtus LifeSci instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Virtus LifeSci Biotech performance during a given time horizon utilizing its historical volatility. Check out Virtus LifeSci Backtesting, Portfolio Optimization, Virtus LifeSci Correlation, Virtus LifeSci Hype Analysis, Virtus LifeSci Volatility, Virtus LifeSci History as well as Virtus LifeSci Performance.
  
Please specify Virtus LifeSci's target price for which you would like Virtus LifeSci odds to be computed.

Virtus LifeSci Target Price Odds to finish below 37.44

The tendency of Virtus Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 37.44  or more in 90 days
 56.38 90 days 37.44 
near 1
Based on a normal probability distribution, the odds of Virtus LifeSci to drop to $ 37.44  or more in 90 days from now is near 1 (This Virtus LifeSci Biotech probability density function shows the probability of Virtus Etf to fall within a particular range of prices over 90 days) . Probability of Virtus LifeSci Biotech price to stay between $ 37.44  and its current price of $56.38 at the end of the 90-day period is about 11.4 .
Considering the 90-day investment horizon the etf has the beta coefficient of 1.4 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Virtus LifeSci will likely underperform. Additionally Virtus LifeSci Biotech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
   Virtus LifeSci Price Density   
       Price  

Predictive Modules for Virtus LifeSci

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Virtus LifeSci Biotech. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Virtus LifeSci's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
54.8956.3857.87
Details
Intrinsic
Valuation
LowRealHigh
55.6257.1158.60
Details
Naive
Forecast
LowNextHigh
56.5558.0459.53
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
55.1355.8956.64
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Virtus LifeSci. Your research has to be compared to or analyzed against Virtus LifeSci's peers to derive any actionable benefits. When done correctly, Virtus LifeSci's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Virtus LifeSci Biotech.

Virtus LifeSci Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Virtus LifeSci is not an exception. The market had few large corrections towards the Virtus LifeSci's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Virtus LifeSci Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Virtus LifeSci within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.16
β
Beta against NYSE Composite1.40
σ
Overall volatility
1.57
Ir
Information ratio -0.07

Virtus LifeSci Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Virtus LifeSci for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Virtus LifeSci Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Virtus LifeSci generated a negative expected return over the last 90 days
Latest headline from seekingalpha.com: First Trust Alerian Disruptive Technology Real Estate ETF declares 0.0311 dividend
The fund holds 98.73% of its assets under management (AUM) in equities

Virtus LifeSci Technical Analysis

Virtus LifeSci's future price can be derived by breaking down and analyzing its technical indicators over time. Virtus Etf technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Virtus LifeSci Biotech. In general, you should focus on analyzing Virtus Etf price patterns and their correlations with different microeconomic environments and drivers.

Virtus LifeSci Predictive Forecast Models

Virtus LifeSci's time-series forecasting models is one of many Virtus LifeSci's etf analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Virtus LifeSci's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the etf market movement and maximize returns from investment trading.

Things to note about Virtus LifeSci Biotech

Checking the ongoing alerts about Virtus LifeSci for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Virtus LifeSci Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Virtus LifeSci generated a negative expected return over the last 90 days
Latest headline from seekingalpha.com: First Trust Alerian Disruptive Technology Real Estate ETF declares 0.0311 dividend
The fund holds 98.73% of its assets under management (AUM) in equities
When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf:
Check out Virtus LifeSci Backtesting, Portfolio Optimization, Virtus LifeSci Correlation, Virtus LifeSci Hype Analysis, Virtus LifeSci Volatility, Virtus LifeSci History as well as Virtus LifeSci Performance.
Note that the Virtus LifeSci Biotech information on this page should be used as a complementary analysis to other Virtus LifeSci's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for Virtus Etf analysis

When running Virtus LifeSci's price analysis, check to measure Virtus LifeSci's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virtus LifeSci is operating at the current time. Most of Virtus LifeSci's value examination focuses on studying past and present price action to predict the probability of Virtus LifeSci's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virtus LifeSci's price. Additionally, you may evaluate how the addition of Virtus LifeSci to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Valuation
Check real value of public entities based on technical and fundamental data
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.